Difluprednate Patent Expiration
Difluprednate was first introduced by Sandoz Inc
Difluprednate Patents
Given below is the list of patents protecting Difluprednate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Durezol |
US6114319 (Pediatric) | Compositions containing difluprednate |
Nov 18, 2019
(Expired) | Sandoz |
| Durezol | US6114319 | Compositions containing difluprednate |
May 18, 2019
(Expired) | Sandoz |
Difluprednate's Family Patents
Explore Our Curated Drug Screens
Difluprednate Generic API Manufacturers
Several generic applications have been filed for Difluprednate. The first generic version for Difluprednate was by Cipla Ltd and was approved on Aug 9, 2021. And the latest generic version is by Epic Pharma Llc and was approved on May 14, 2024.
Given below is the list of companies who have filed for Difluprednate generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Difluprednate. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | emulsion | Prescription | OPHTHALMIC | AB | Nov 17, 2021 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. CIPLA
Cipla Ltd has filed for 1 generic for Difluprednate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | emulsion | Prescription | OPHTHALMIC | AB | Aug 9, 2021 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Difluprednate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | emulsion | Prescription | OPHTHALMIC | AB | Nov 16, 2022 |
4. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Difluprednate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | emulsion | Prescription | OPHTHALMIC | AB | May 14, 2024 |